Ingenol mebutate gel: A guide to its use in actinic keratosis in the EU

Pas encore traduit Pas encore traduit
Catégorie Primary study
JournalDrugs and Therapy Perspectives
Year 2014
Ingenol mebutate gel (Picato®) is indicated for the topical treatment of actinic keratosis. Field-directed therapy with topical ingenol mebutate (150 μg/g gel applied once daily for 3 consecutive days for actinic keratoses on the face or scalp, and 500 μg/g gel applied once daily for 2 consecutive days for actinic keratoses on the trunk or extremities) resulted in significantly higher complete and partial clearance rates at day 57 than treatment with vehicle gel. Clearance was generally sustained during 1-year follow-up. Moreover, relative to cryosurgery alone, a 3-day course of ingenol mebutate 150 μg/g gel applied to the face and scalp 3 weeks after cryosurgery improved clearance of actinic keratosis at 11 weeks. Transient local skin responses are very common after initiation of ingenol mebutate gel. © 2014 Springer International Publishing.
Epistemonikos ID: c5e598e132e2f605a472e3f3f1d6e43782982a9b
First added on: Feb 06, 2025